These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37123277)

  • 21. VE-cadherin cleavage in sleep apnoea: new insights into intermittent hypoxia-related endothelial permeability.
    Harki O; Tamisier R; Pépin JL; Bailly S; Mahmani A; Gonthier B; Salomon A; Vilgrain I; Faury G; Briançon-Marjollet A
    Eur Respir J; 2021 Oct; 58(4):. PubMed ID: 33737411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages.
    Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X
    Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation.
    Htoo AK; Greenberg H; Tongia S; Chen G; Henderson T; Wilson D; Liu SF
    Sleep Breath; 2006 Mar; 10(1):43-50. PubMed ID: 16491391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.
    Arnaud C; Dematteis M; Pepin JL; Baguet JP; Lévy P
    Semin Immunopathol; 2009 Jun; 31(1):113-25. PubMed ID: 19404644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of nocturnal oxygen and CPAP on the ventilatory response to hypoxia in OSA patients free of overt cardiovascular disease.
    Pun M; Beaudin AE; Raneri JK; Anderson TJ; Hanly PJ; Poulin MJ
    Exp Neurol; 2021 Dec; 346():113852. PubMed ID: 34461058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Models of intermittent hypoxia and obstructive sleep apnea: molecular pathways and their contribution to cancer.
    Hunyor I; Cook KM
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R669-R687. PubMed ID: 29995459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent Hypoxia and Its Impact on Nrf2/HIF-1α Expression and ABC Transporters: An in Vitro Human Blood-Brain Barrier Model Study.
    Zolotoff C; Voirin AC; Puech C; Roche F; Perek N
    Cell Physiol Biochem; 2020 Dec; 54(6):1231-1248. PubMed ID: 33326735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach.
    Sforza E; Roche F
    Hypoxia (Auckl); 2016; 4():99-108. PubMed ID: 27800512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia.
    Hung MW; Kravtsov GM; Lau CF; Poon AM; Tipoe GL; Fung ML
    J Pineal Res; 2013 Oct; 55(3):247-56. PubMed ID: 23869411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obstructive Sleep Apnea-Associated Intermittent Hypoxia-Induced Immune Responses in Males, Pregnancies, and Offspring.
    Song R; Baker TL; Watters JJ; Kumar S
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obstructive Sleep Apnea Activates HIF-1 in a Hypoxia Dose-Dependent Manner in HCT116 Colorectal Carcinoma Cells.
    Martinez CA; Kerr B; Jin C; Cistulli PA; Cook KM
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia.
    Schulz R; Hummel C; Heinemann S; Seeger W; Grimminger F
    Am J Respir Crit Care Med; 2002 Jan; 165(1):67-70. PubMed ID: 11779732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular changes, cardiovascular disease and obstructive sleep apnea.
    Ramar K; Caples SM
    Future Cardiol; 2011 Mar; 7(2):241-9. PubMed ID: 21453030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver disease.
    Ji Y; Liang Y; Mak JCW; Ip MSM
    Sleep Med; 2022 Jul; 95():16-28. PubMed ID: 35537279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea.
    Lavie L
    Front Biosci (Elite Ed); 2012 Jan; 4(4):1391-403. PubMed ID: 22201964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Chip for Cyclic Stretch and Intermittent Hypoxia Cell Exposures Mimicking Obstructive Sleep Apnea.
    Campillo N; Jorba I; Schaedel L; Casals B; Gozal D; Farré R; Almendros I; Navajas D
    Front Physiol; 2016; 7():319. PubMed ID: 27524971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obstructive sleep apnea and endothelial progenitor cells.
    Wang Q; Wu Q; Feng J; Sun X
    Patient Prefer Adherence; 2013 Oct; 7():1077-90. PubMed ID: 24204127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition.
    Arnaud C; Beguin PC; Lantuejoul S; Pepin JL; Guillermet C; Pelli G; Burger F; Buatois V; Ribuot C; Baguet JP; Mach F; Levy P; Dematteis M
    Am J Respir Crit Care Med; 2011 Sep; 184(6):724-31. PubMed ID: 21680945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome.
    Gautier-Veyret E; Bäck M; Arnaud C; Belaïdi E; Tamisier R; Lévy P; Arnol N; Perrin M; Pépin JL; Stanke-Labesque F
    Pharmacol Res; 2018 Aug; 134():311-319. PubMed ID: 29920371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of endothelial dysfunction in obstructive sleep apnea.
    Atkeson A; Jelic S
    Vasc Health Risk Manag; 2008; 4(6):1327-35. PubMed ID: 19337546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.